Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 19/20 | 0.53 |
| ▸ | F2 | P00734 | 16/20 | 0.51 |
| ▸ | PRSS1 | P07477 | 10/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14632437 | 1.00 | F10 (0.53) | F10F2PRSS1KDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL14632408 | 0.99 | F10 (0.52) | F10F2PRSS1KDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL14632406 | 0.99 | F10 (0.52) | F10F2PRSS1KDM4EMEN1 | |
| Hydrochloric Acid SCHEMBL14632606 | 0.95 | F10 (0.50) | F10F2PRSS1 | |
| Hydrochloric Acid SCHEMBL14632425 | 0.95 | F10 (0.50) | F10F2PRSS1 | |
| SCHEMBL10311098 | 0.80 | ALOX5 (0.47) | KDM4EMEN1ALDH1A1GAAHPGD | |
| SCHEMBL5322918 | 0.80 | F2 (0.47) | F10F2PRSS1 | |
| SCHEMBL13603832 | 0.79 | SMN1; SMN2 (0.46) | MEN1ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL8104378 | 0.79 | SMN1; SMN2 (0.46) | MEN1ALDH1A1KMT2AHSD17B10 | |
| SCHEMBL6502072 | 0.79 | NOTUM (0.53) | ALDH1A1HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130023563-A1 | AMIDINOANILINE DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2013-01-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023563-A1 | AMIDINOANILINE DERIVATIVE | F11, SERPINC1, F8 | F10 17/4885F2 4/4885PRSS1 35/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.